NDFOS Co. Ltd (238090) - Total Liabilities

Latest as of September 2025: ₩14.82 Billion KRW ≈ $10.04 Million USD

Based on the latest financial reports, NDFOS Co. Ltd (238090) has total liabilities worth ₩14.82 Billion KRW (≈ $10.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of NDFOS Co. Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

NDFOS Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how NDFOS Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see NDFOS Co. Ltd assets under control.

NDFOS Co. Ltd Competitors by Total Liabilities

The table below lists competitors of NDFOS Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Quest Resource Holding Corp
NASDAQ:QRHC
USA $107.49 Million
ilShinbiobase Co. Ltd
KQ:068330
Korea ₩6.72 Billion
Kayee International Group Co Ltd
TW:2939
Taiwan NT$250.11 Million
Asia Precision Public Company Limited
BK:APCS
Thailand ฿1.54 Billion
Borealis Foods Inc.
NASDAQ:BRLS
USA $69.25 Million
Bintai Kinden Corporation Bhd
KLSE:6998
Malaysia RM154.83 Million
Primary Health Properties
LSE:PHP
UK GBX3.54 Billion
Centric Holdings S.A
AT:CENTR
Greece €11.16 Million

Liability Composition Analysis (2014–2024)

This chart breaks down NDFOS Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NDFOS Co. Ltd (238090) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.96 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.13 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NDFOS Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NDFOS Co. Ltd (2014–2024)

The table below shows the annual total liabilities of NDFOS Co. Ltd from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 ₩15.70 Billion
≈ $10.64 Million
-5.75%
2023-12-31 ₩16.66 Billion
≈ $11.29 Million
-51.77%
2022-12-31 ₩34.55 Billion
≈ $23.41 Million
-50.44%
2021-12-31 ₩69.71 Billion
≈ $47.24 Million
+67.85%
2020-12-31 ₩41.53 Billion
≈ $28.15 Million
-47.23%
2019-12-31 ₩78.70 Billion
≈ $53.34 Million
+71.88%
2018-12-31 ₩45.79 Billion
≈ $31.03 Million
+275.02%
2017-12-31 ₩12.21 Billion
≈ $8.27 Million
+47.33%
2016-12-31 ₩8.29 Billion
≈ $5.62 Million
-20.84%
2015-12-31 ₩10.47 Billion
≈ $7.09 Million
-23.81%
2014-12-31 ₩13.74 Billion
≈ $9.31 Million
--

About NDFOS Co. Ltd

KQ:238090 Korea Specialty Chemicals
Market Cap
$29.41 Million
₩43.40 Billion KRW
Market Cap Rank
#23948 Global
#1677 in Korea
Share Price
₩1907.00
Change (1 day)
-2.46%
52-Week Range
₩1549.00 - ₩3950.00
All Time High
₩24250.00
About

NDFOS Co., Ltd. operates as a tape and film company in South Korea. The company offers adhesive tapes, such as waterproof tapes, light-shielding tapes, heat reaction tapes, battery fixing tapes, thin film tapes, convergence type functional tapes, and heat radiation tapes; functional films, including automobiles, industries, and everyday life. It also develops ARS and STR, anticancer drugs for can… Read more